Phio Pharmaceuticals (PHIO) Stock Statistics & Valuation Metrics

Phio Pharmaceuticals has a market cap or net worth of $11.18M. The enterprise value is -$1.09M.

Phio Pharmaceuticals has 4,798,154 shares outstanding. The number of shares has decreased by -2.65% in one year.

Phio Pharmaceuticals’s return on equity (ROE) is -1.51 and return on invested capital (ROIC) is -156.40%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Phio Pharmaceuticals had revenue of 0.00 and earned -7.15M in profits. Earnings per share was -0.91.

In the last 12 months, operating cash flow was -7.33M and capital expenditures -48.00K, giving a free cash flow of -7.38M billion.

Phio Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―

Phio Pharmaceuticals upcoming earnings date is Aug 7, 2025, Before Open (Confirmed).

Phio Pharmaceuticals as a current ratio of 5.65, with Debt / Equity ratio of 0.00%

In the past 12 months, Phio Pharmaceuticals has paid 0.00 in taxes.

Phio Pharmaceuticals EV to EBITDA ratio is -1.24, with an EV/FCF ratio of -1.24.

Phio Pharmaceuticals has $13.28M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$13.28M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Phio Pharmaceuticals is $14.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy